Pharmacokinetics of β-l-2′,3′-Dideoxy-5-Fluorocytidine in Rhesus Monkeys

β-l-2′,3′-Dideoxy-5-fluorocytidine (β-l-FddC), a novel cytidine analog with an unnatural β-l sugar configuration, has been demonstrated by our group and others to exhibit highly selective in vitro activity against human immunodeficiency virus types 1 and 2 and hepatitis B virus. This encouraging in...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Martin, Lee T., Cretton-Scott, Erika, Schinazi, Raymond F., Zhou, Xiao-Jian, McClure, Harold M., Mathe, Christophe, Gosselin, Gilles, Imbach, Jean-Louis, Sommadossi, Jean-Pierre
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89226/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10103200/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.4.920
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!